Existing models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma

por Meniawy, T M, Creaney, J, Lake, R A, Nowak, A K
Publicado 2013

Response to comment on ‘Existing prognostic models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma'

por Meniawy, T M, Creaney, J, Lake, R A, Nowak, A K
Publicado 2014

Post-chemotherapy T-cell recovery is a marker of improved survival in patients with advanced thoracic malignancies

por McCoy, M J, Lake, R A, van der Most, R G, Dick, I M, Nowak, A K
Publicado 2012

A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma

por Nowak, A K, Byrne, M J, Williamson, R, Ryan, G, Segal, A, Fielding, D, Mitchell, P, Musk, A W, Robinson, B W S
Publicado 2002

Overexpression and altered glycosylation of MUC1 in malignant mesothelioma

por Creaney, J, Segal, A, Sterrett, G, Platten, M A, Baker, E, Murch, A R, Nowak, A K, Robinson, B W S, Millward, M J
Publicado 2008

Low stromal Foxp3(+) regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer

por McCoy, M J, Hemmings, C, Miller, T J, Austin, S J, Bulsara, M K, Zeps, N, Nowak, A K, Lake, R A, Platell, C F
Publicado 2015

Deterministic and electrically tunable bright single-photon source

por Nowak, A. K., Portalupi, S. L., Giesz, V., Gazzano, O., Dal Savio, C., Braun, P.-F., Karrai, K., Arnold, C., Lanco, L., Sagnes, I., Lemaître, A., Senellart, P.
Publicado 2014

Axial and triaxial degrees of freedom in $^{72}$Zn

por Hellgartner, S, Mücher, D, Wimmer, K, Bildstein, V, Egido, J L, Gernhäuser, R, Krücken, R, Nowak, A K, Zielinska, M, Bauer, C, Benito, M L L, Bottoni, S, De Witte, H, Elseviers, J, Fedorov, D, Flavigny, F, Illana, A, Klintefjord, M, Kröll, T, Lutter, R, Marsh, B, Orlandi, R, Pakarinen, J, Raabe, R, Rapisarda, E, Reichert, S, Reiter, P, Scheck, M, Seidlitz, M, Siebeck, B, Siesling, E, Steinbach, T, Stora, T, Vermeulen, M, Voulot, D, Warr, N, Wenander, F J C
Publicado 2023